Details for New Drug Application (NDA): 021184
✉ Email this page to a colleague
The generic ingredient in TAZORAC is tazarotene. There are eight drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the tazarotene profile page.
Summary for 021184
Tradename: | TAZORAC |
Applicant: | Allergan |
Ingredient: | tazarotene |
Patents: | 0 |
Suppliers and Packaging for NDA: 021184
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
AVAGE | tazarotene | CREAM;TOPICAL | 021184 | NDA | ALMIRALL, LLC | 16110-915 | 16110-915-30 | 1 TUBE in 1 CARTON (16110-915-30) / 30 g in 1 TUBE |
AVAGE | tazarotene | CREAM;TOPICAL | 021184 | NDA | ALMIRALL, LLC | 16110-915 | 16110-915-60 | 1 TUBE in 1 CARTON (16110-915-60) / 60 g in 1 TUBE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CREAM;TOPICAL | Strength | 0.05% | ||||
Approval Date: | Sep 29, 2000 | TE: | AB | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CREAM;TOPICAL | Strength | 0.1% | ||||
Approval Date: | Sep 29, 2000 | TE: | AB | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CREAM;TOPICAL | Strength | 0.1% | ||||
Approval Date: | Sep 30, 2002 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 021184
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Allergan | AVAGE | tazarotene | CREAM;TOPICAL | 021184-003 | Sep 30, 2002 | 5,089,509 | ⤷ Subscribe |
Allergan | TAZORAC | tazarotene | CREAM;TOPICAL | 021184-002 | Sep 29, 2000 | 5,089,509 | ⤷ Subscribe |
Allergan | TAZORAC | tazarotene | CREAM;TOPICAL | 021184-001 | Sep 29, 2000 | 5,089,509 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription